Hercules' Bio-Rad Laboratories Inc. announced Friday that it has changed the symbol for its Class A shares on the American Stock Exchange from "BIO.A" to "BIO." The change too effect at the opening of ...
Bio-Rad BIO has been facing the impact of funding issues in the biopharmaceutical or BioPharma space, macroeconomic headwinds and competitive pressure. The stock carries a Zacks Rank #4 (Sell) ...
Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback